Summary and opinion by Wendy Anderson.
The first randomized, controlled, research for Post-Traumatic Stress Disorder that will use the actual cannabis plant and not just oils or synthesized cannabis has been given the okay by the Drug Enforcement Agency.
The research’s nonprofit sponsor, Multidisciplinary Association for Psychedelic Studies (MAPS), says that the approval gives the researchers permission to buy cannabis from the National Institute of Drug Abuse. Then once the cannabis has been purchased they can begin recruiting and enrolling entrants, which can happen as early June. The participants will include 76 veterans with treatment-resistant PTSD, and the study will use various strains and potency for comparison.
MAPS was awarded a 2 million dollar grant in Colorado in 2014 and then another 5.6 million dollars to several other organizations to support medical marijuana research.
Marcel Bonn-Miller with the University of Pennsylvania Perelman School of Medicine is overseeing the project. There will also be work conducted at the University of Colorado School of Medicine.
Read the original article here.
Comments will be approved before showing up.
Liquid error: Could not find asset snippets/mailchimp-popup.liquid